Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
The peptide was given the designation PL-10 and PL14736 during early clinical trial development by Pliva, a Croatian pharmaceutical company, specifically for inflammatory bowel disease
By administering BPC-157 in oral capsule form, subjects of research studies can easily incorporate this regenerative peptide into their daily routine without the need for injections which can cause discomfort
The health and safety hazards associated with the handling of peptides in a research setting
31 Since there is significant residual CVD risk in patients with diabetes, even after accounting for traditional risk factors, the development of novel therapeutic avenues is needed to address it
It really drives home the point that moving from a stable, lyophilized peptide to a functional solution hinges on picking the right solvent and using the right technique
References PubMed Preclinical safety evaluation of body protective compound-157, a potential drug for treating various wounds Current Pharmaceutical Design (PubMed) Stable gastric pentadecapeptide BPC-157: novel therapy in gastrointestinal tract PMC Utilizing developmentally essential secreted peptides such as Thymosin Beta-4 for regenerative therapies Annals of the New York Academy of Sciences (PubMed) Thymosin beta 4 and wound healing: new ideas PMC Emerging use of BPC-157 in orthopaedic sports medicine: a systematic review Johns Hopkins Arthritis Center How to give a subcutaneous injection PMC Subcutaneous drug delivery review: pharmacologic considerations ASIPP / Alternative Therapies in Health and Medicine Intra-articular injection of BPC-157 for multiple types of knee pain A4M Thymosin Beta-4 professional monograph PubMed Detection of thymosin beta-4 and related peptides in sport drug testing Journal of Physiology and Pharmacology (PubMed) BPC-157 activity at very low doses without toxicity in animal studies Expert Opinion on Biological Therapy (PubMed) Thymosin beta-4 and its role in wound healing CDC Vaccine administration: subcutaneous route (angle/site
US$ 26.45
US$ 24.28
US$ 25.16
